BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25872392)

  • 1. [Prognostic factors for uveal melanoma].
    Amiryan AG; Saakyan SV
    Vestn Oftalmol; 2015; 131(1):90-95. PubMed ID: 25872392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of survival in metastatic uveal melanoma.
    Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
    Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
    Bagger M; Smidt-Nielsen I; Andersen MK; Jensen PK; Heegaard S; Andersen KK; Friis S; Kiilgaard JF
    Ophthalmology; 2018 Dec; 125(12):1969-1976. PubMed ID: 29705056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.
    Bol KF; Mensink HW; Aarntzen EH; Schreibelt G; Keunen JE; Coulie PG; de Klein A; Punt CJ; Paridaens D; Figdor CG; de Vries IJ
    Am J Ophthalmol; 2014 Nov; 158(5):939-47. PubMed ID: 25038326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival.
    Augsburger JJ; Corrêa ZM; Trichopoulos N
    Am J Ophthalmol; 2011 Jul; 152(1):5-9.e1. PubMed ID: 21601175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
    Park SJ; Oh CM; Yeon B; Cho H; Park KH
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
    Ophthalmic Oncology Task Force
    Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
    Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
    JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very long-term prognosis of patients with malignant uveal melanoma.
    Kujala E; Mäkitie T; Kivelä T
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4651-9. PubMed ID: 14578381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan.
    Liu YC; Tsai CC; Lee FL; Lee SM; Kao SC
    Acta Ophthalmol; 2013 Nov; 91(7):e583-4. PubMed ID: 24131706
    [No Abstract]   [Full Text] [Related]  

  • 12. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
    Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
    Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variates of survival in metastatic uveal melanoma.
    Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
    J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
    Kroll S; Char DH; Quivey J; Castro J
    Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients.
    Piperno-Neumann S; Servois V; Mariani P; Plancher C; Lévy-Gabriel C; Lumbroso-Le Rouic L; Couturier J; Asselain B; Desjardins L; Cassoux N
    J Fr Ophtalmol; 2015 Jun; 38(6):526-34. PubMed ID: 25978872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Prognosis in Uveal Melanoma.
    Correa ZM
    Cancer Control; 2016 Apr; 23(2):93-8. PubMed ID: 27218785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival.
    Damato BE; Heimann H; Kalirai H; Coupland SE
    JAMA Ophthalmol; 2014 May; 132(5):605-13. PubMed ID: 24626610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.